Exane Derivatives Has $1.03 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

United Capital Financial Advisers Llc bought 14,643 shares as the company's stock declined 8.05% while stock markets rallied. Capital International Investors now owns 11,217,015 shares of the biopharmaceutical company's stock valued at $908,803,000 after acquiring an additional 5,205,983 shares during the last quarter. Hollow Brook Wealth Management Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $106.19 billion market cap company. About 3.92 million shares traded.

Gilead Sciences Inc. (NASDAQ:GILD) now has a Weekly Volatility of 1.75% percent while its Monthly Volatility is at 2.36% percent. It has underperformed by 38.50% the S&P500.

Comgest Global Investors Sas increased its stake in Icon Plc (ICLR) by 40.25% based on its latest 2017Q3 regulatory filing with the SEC. It increased, as 96 investors sold Gilead Sciences, Inc. shares while 488 reduced holdings. The institutional investor held 10.41 million shares of the major banks company at the end of 2017Q3, valued at $574.02 million, up from 9.91 million at the end of the previous reported quarter. Regions Financial Corp who had been investing in Ecolab Inc for a number of months, seems to be bullish on the $39.51B market cap company. The stock increased 1.29% or $0.97 during the last trading session, reaching $75.93. About 331,069 shares traded. Wells Fargo & Company (NYSE:WFC) has risen 9.67% since March 13, 2017 and is uptrending. It has outperformed by 0.73% the S&P500. (NASDAQ:GILD). Spectrum Asset Inc (Nb Ca) holds 0.21% or 3,000 shares in its portfolio. Tokio Marine Asset Mgmt Co Ltd reported 74,862 shares stake. After $1.60 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -0.63% negative EPS growth. Therefore 70% are positive. Citigroup upgraded Gilead Sciences from a "neutral" rating to a "buy" rating and reduced their price target for the company from $88.80 to $76.00 in a research report on Tuesday, January 30th.

Exane Derivatives cut its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD) has "Buy" rating given on Friday, September 15 by Robert W. Baird. Jefferies reinitiated Gilead Sciences, Inc. Morgan Stanley maintained the shares of GILD in report on Thursday, May 26 with "Equal-Weight" rating. Citigroup has "Buy" rating and $103.0 target. Leerink Swann decreased their price objective on Gilead Sciences from $86.00 to $83.00 and set a "market perform" rating on the stock in a research note on Wednesday, February 7th. Oppenheimer initiated the stock with "Hold" rating in Wednesday, October 4 report. Maxim Group boosted its rating on the $105.70B market capitalized company to a Buy, and made a decision to leave its target price of $94.0 on GILD shares. (NASDAQ:GILD) has "Hold" rating given on Monday, August 28 by Maxim Group. UBS initiated Kellogg Company (NYSE:K) rating on Wednesday, February 24. The firm has "Buy" rating given on Wednesday, October 28 by Maxim Group. The firm owned 5,037 shares of the biopharmaceutical company's stock after buying an additional 743 shares during the period.

Since October 2, 2017, it had 0 insider purchases, and 13 insider sales for $41.72 million activity. The insider MARTIN JOHN C sold $4.18 million. Cohen & Steers Incorporated reported 0.03% in Gilead Sciences, Inc. Monarch Cap Mngmt stated it has 1.68% in Gilead Sciences, Inc.

In related news, EVP Gregg H. Alton sold 15,000 shares of the stock in a transaction dated Tuesday, January 2nd.

Investors sentiment increased to 0.3 in Q3 2017. Its down 0.15, from 0.88 in 2017Q2.

Other hedge funds also recently made changes to their positions in the company. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. (NASDAQ:GILD). Ims Capital has 17,830 shares for 0.93% of their portfolio. Vetr cut Gilead Sciences from a "buy" rating to a "hold" rating and set a $91.25 price target for the company.in a research note on Monday, January 29th. Invesco accumulated 0.53% or 17.81M shares. Columbia Ptnrs L L C Inv Mgmt holds 0.03% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Bkd Wealth Advsrs reported 8,398 shares. Caisse De Depot Et Placement Du Quebec has 2.17 million shares.

Orleans Capital Management Corp, which manages about $1.29B and $133.55M US Long portfolio, decreased its stake in Halliburton Co (NYSE:HAL) by 10,230 shares to 61,138 shares, valued at $2.81 million in 2017Q3, according to the filing. Continental Advsr Limited Liability Corp accumulated 52,500 shares. Mirae Asset Glob Com Limited owns 8,374 shares for 0.02% of their portfolio. Comerica Secs holds 0.47% or 41,993 shares in its portfolio. First Foundation Advsr reported 379,995 shares. Wellington Shields Com Ltd Liability Com owns 7,952 shares for 0.09% of their portfolio. (NASDAQ:GILD). Washington Tru Bankshares has invested 0.02% of its portfolio in Gilead Sciences, Inc. Credit Suisse initiated Gilead Sciences, Inc. Macquarie Group Ltd. boosted its stake in shares of Gilead Sciences by 26.6% in the third quarter. The firm has "Outperform" rating by Oppenheimer given on Tuesday, November 3. (NASDAQ:TRUP) rating on Thursday, September 21. The stock has "Hold" rating by Needham on Monday, December 18.

Gilead Sciences, Inc is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need.

Since September 14, 2017, it had 0 buys, and 1 sale for $966,233 activity. The stock of Wells Fargo & Company (NYSE:WFC) has "Buy" rating given on Thursday, June 22 by RBC Capital Markets. As per Friday, August 4, the company rating was maintained by RBC Capital Markets. "(NASDAQ:GILD) Stake Decreased by CENTRAL TRUST Co" was originally published by The Lincolnian Online and is the property of of The Lincolnian Online. Metropolitan Life Insur Ny, New York-based fund reported 658,277 shares. Da Davidson And holds 0.01% in Kellogg Company (NYSE:K) or 11,759 shares.

Old Republic International Corp, which manages about $3.02B US Long portfolio, decreased its stake in Cummins Inc (NYSE:CMI) by 90,500 shares to 193,500 shares, valued at $32.51 million in 2017Q3, according to the filing. Dalton Greiner Hartman Maher Com has 0.69% invested in Union Pacific Corporation (NYSE:UNP). The company had a trading volume of 6,904,355 shares, compared to its average volume of 9,650,000. 307.00 million shares or 3.54% more from 296.50 million shares in 2017Q2 were reported.

Investors sentiment increased to 1.19 in Q3 2017. Following the sale, the executive vice president now directly owns 102,715 shares in the company, valued at approximately $8,241,851.60. S Squared Technologies Ltd Liability Corp reported 1.64% stake. 21,711 are owned by Northcoast Asset Mgmt Ltd Company. Ruffer Limited Liability Partnership accumulated 13,849 shares. (NASDAQ:GILD) or 60,000 shares. Pictet Asset Management Ltd has invested 0.79% in Gilead Sciences, Inc. The rating was maintained by Deutsche Bank on Tuesday, August 11 with "Buy". Its down 0.23, from 1.03 in 2017Q2.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related Articles